Remedent Inc (REMI) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access REMI Annual Balance Sheets →
Balance sheet performance over multiple periods helps investors evaluate the financial resilience of Remedent Inc.
Quarterly Report, GAAP in USD millions
ITEM
(Dec 31 2020)
(Sep 30 2020) (Jun 30 2020) (Mar 31 2020) (Dec 31 2019)
Assets
Cash & cash equivalent0.08
Cash & Short-term Investments0.00
Accounts receivable0.47
Inventories0.11
Prepaid Expense, Current AS0.03
Total Current Assets0.70
Equipment/Property/Plant Net0.08
Intangible Assets0.00
Other Assets, Noncurrent0.00
Investment In Subsidiary One2.04
Investment In Subsidiary Two1.29
Investments In Subsidiary Four3.46
Total Assets7.56
Liabilities
Accounts Payable, Current AC2.37
Accrued Liabilities, Current AC0.40
Other Liabilities, Current0.00
Deferred Revenue, Current DE0.14
Total Current Liabilities2.91
Long-term debt0.00
Total Long-term Debt0.00
Other liabilities, Noncurrent0.01
OperatingLeaseLiabilityNoncurrent0.01
Total Liabilities2.92
Stockholders' Equity
Obligation To Issue Shares0.10
Common Stock Value0.02
Treasury Stock Value-0.83
Additional Paid In Capital Common Stock24.91
Retained Earnings / Accumulated Deficit-18.48
Other Equity-1.15
Common Stockholder's Equity4.56
Non-controlling interests & other0.08
Total Stockholder's Equity4.64
Liabilities & Stockholder's Equity7.56
4 historic quarters locked

Sign in to unlock the full Remedent Inc balance sheet history.

About REMI Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-Q
  • Filed with the SEC: n/a

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.